Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianling Decoction (Jianling Tang) is a traditional Chinese medicine (TCM) herbal formula originally described by Zhang Xichun in the "Records of Traditional Chinese and Western Medicine in Combination." It is specifically indicated for "Wind Yang Floating Upwards" syndrome, a TCM pattern often associated with hypertension and the acute or recovery phases of ischemic stroke. The formula typically contains Achyranthis Bidentatae Radix (Huai Niuxi), Haematitum (Dai Zhe Shi), Rehmanniae Radix (Sheng Di Huang), and other sedative and yin-nourishing herbs. In modern clinical research, it is being investigated for its ability to modulate the gut microbiota-gut-brain axis, potentially reducing neuroinflammation and improving neurological outcomes following cerebral ischemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianling decoction.